RxDoctor Payments DataLook up a doctor →

Alisa Orr

Adult Health · Idaho Falls, IDNPI 1851988265

Payments from drug & device makers

$10,459in general payments, 2019–2025

Across 542 payments — averaging $19.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$938
  • Novartis$749
  • Johnson & Johnson$733
  • Pfizer$663
  • Daiichi Sankyo Inc.$564
  • Merck$533
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca42$938
Novartis48$749
Johnson & Johnson38$733
Pfizer52$663
Daiichi Sankyo Inc.30$564
Merck26$533
AbbVie19$378
Sanofi22$368
Genentech USA, Inc.21$350
Myriad Genetic Laboratories, Inc.4$308
Takeda Pharmaceuticals U.S.A., Inc.13$296
Bristol Myers Squibb15$294
Eisai Inc.14$294
Amgen16$273
Lilly USA, LLC14$252
Tersera Therapeutics LLC12$222
AVEO Pharmaceuticals, Inc.3$205
Astellas Pharma US Inc10$175
Seagen Inc.11$172
Sobi, Inc9$165
GSK9$158
Dendreon Pharmaceuticals LLC7$153
Pharmacyclics LLC, An Abbvie Company3$146
Puma Biotechnology, Inc.7$138
Beigene USA, Inc.6$129
Servier Pharmaceuticals LLC6$121
Jazz Pharmaceuticals Inc.4$106
E.r. Squibb & Sons, L.L.C.4$103
Incyte Corporation6$100
Genmab U.S., Inc.5$95
Regeneron Healthcare Solutions, Inc.5$93
Beone Medicines USA, Inc.3$90
Stemline Therapeutics Inc.4$87
EMD Serono, Inc.5$79
Bayer4$69
Iovance Biotherapeutics, Inc.3$60
Deciphera Pharmaceuticals Inc.3$54
Boehringer Ingelheim2$51
Geron Corporation2$51
Coherus Oncology, Inc.2$49
Array Biopharma Inc3$43
Karyopharm Therapeutics Inc.2$42
Medtronic2$40
EUSA Pharma (US) LLC2$39
Spectrum Pharmaceuticals Inc.2$36
Rigel Pharmaceuticals, Inc.1$33
Legend Biotech USA Inc.1$33
Pharmacosmos Therapeutics Inc.2$33
Fresenius Kabi USA, LLC2$30
Blueprint Medicines Corporation2$30
G1 Therapeutics, Inc.2$28
Pharmaessentia USA Corporation1$23
Syndax Pharmaceuticals, Inc.1$22
Novocure Inc.1$22
Springworks Therapeutics, Inc.1$20
ADC Therapeutics America, Inc.1$20
Exelixis Inc.1$19
Agios Pharmaceuticals, Inc.1$18
Mirati Therapeutics, Inc.1$18
Organon2$16

How this compares

$10,459 in reported general payments places this provider in the 95th percentile of 38 adult health providers in Idaho.

See all adult health providers in Idaho

Medicare billing

Part B allowed, 2024
$45,064
Medicare patients
280
Services billed
550

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Idaho Falls

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →